CROSSROADS STRATEGIES, LLC for MERCK & CO., INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program, antimicrobial resistance legislation, VICP Program, and insulin price cap; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA); Animal Drug User Fee Reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Drug Pricing; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; CMMI Proposed Accelerated Approval Payment Policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Implementation of Tax Cuts and Jobs Act (P.L.115-97). Issues related to R&D tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical IP and supply chain.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
Issues related to appropriations and federal health programs; reimbursement issues; FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Copyright/Patent/Trademark CPT
Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.